Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.090
+0.040 (1.95%)
Jul 3, 2025, 1:00 PM - Market closed
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $711.15 million as of July 3, 2025. Its market cap has decreased by -1.80% in one year.
Market Cap
711.15M
Enterprise Value
260.89M
1-Year Change
-1.80%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $711.15M, an increase of 307.59%. That is a compound annual growth rate of 33.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 711.15M | -20.57% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 707.77B |
| Johnson & Johnson | 378.31B |
| AbbVie | 338.05B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 293.82B |
| Abbott Laboratories | 237.10B |
| Novartis AG | 236.92B |
| AstraZeneca | 215.00B |